Champions Oncology (CSBR) Change in Account Payables (2010 - 2026)

Champions Oncology (CSBR) has 17 years of Change in Account Payables data on file, last reported at -$1.4 million in Q3 2026.

• On a quarterly basis, Change in Account Payables fell 446.72% year-over-year to -$1.4 million in Q3 2026; TTM through Jul 2026 was $722000.0, a 193.4% increase from a year earlier, with the FY2026 full-year figure at $2.6 million, up 246.26% from the prior year.
• Change in Account Payables for Q3 2026 stood at -$1.4 million, down from $1.3 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $2.1 million in Q4 2022 and bottomed at -$1.4 million in Q3 2026.
• Historically, Change in Account Payables has averaged $93789.5 across 5 years, with a median of -$188000.0 in 2025.
• The largest YoY upside for Change in Account Payables was 1443.28% in 2022 against a maximum downside of 635.57% in 2022.
• Year by year, Change in Account Payables stood at $2.1 million in 2022, then sank by 159.19% to -$1.2 million in 2023, then soared by 68.79% to -$382000.0 in 2024, then surged by 443.19% to $1.3 million in 2025, then plunged by 208.7% to -$1.4 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$1.4 million in Q3 2026, $1.3 million in Q2 2026, and -$437000.0 in Q1 2026.